HuGE Literature Finder
Records
1
-
21
| Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Scientific reports 2021 Sep 11 (1): 18009. Zaki Mark M, Mashouf Leila A, Woodward Eleanor, Langat Pinky, Gupta Saksham, Dunn Ian F, Wen Patrick Y, Nahed Brian V, Bi Wenya Lin |
| Next-Generation Sequencing in the Diagnosis of Metastatic Lesions: Reclassification of a Glioblastoma as an Endometrial Cancer Metastasis to the Brain. The oncologist 2021 Aug . Leung Shuk On Annie, Foley Olivia, Chapel David, Da Silva Annacarolina, Nucci Marisa, Muto Michael G, Campos Susa |
| Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy. Frontiers in oncology 2021 11 640910. Hu Li, Cheng Xingbo, Binder Zev, Han Zhibin, Yin Yibo, O'Rourke Donald M, Wang Sida, Feng Yumeng, Weng Changjiang, Wu Anhua, Lin Zhig |
| Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas. Journal of translational medicine 2020 Aug 18 (1): 305. Zhang Hao, Fan Fan, Yu Yuanqiang, Wang Zeyu, Liu Fangkun, Dai Ziyu, Zhang Liyang, Liu Zhixiong, Cheng Qu |
| Gliosarcoma Is Driven by Alterations in PI3K/Akt, RAS/MAPK Pathways and Characterized by Collagen Gene Expression Signature. Cancers 2019 Feb 11 (3): . Wojtas Bartosz, Gielniewski Bartlomiej, Wojnicki Kamil, Maleszewska Marta, Mondal Shamba S, Nauman Pawel, Grajkowska Wieslawa, Glass Rainer, Schüller Ulrich, Herold-Mende Christel, Kaminska Boze |
| Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches. Journal of oncology 2019 2019 4878547. Ellis H P, McInerney C E, Schrimpf D, Sahm F, Stupnikov A, Wadsley M, Wragg C, White P, Prise K M, McArt D G, Kurian K |
| Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
| Human Cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas. Neoplasma 2018 Mar 65 (3): 431-435. Han S, Wang P F, Xing Y X, Song H W, Yao K, Lin Z |
| WITHDRAWAL: Significant effect of anti-tyrosine kinase inhibitor (Gefitinib) on overall survival of the Glioblastoma (GBM) patients in the backdrop of mutational status of EGFR and PTEN genes. Journal of neurosurgical sciences 2018 Feb . Arif Sajad H, Pandith Arshad A, Tabasum Rehana, Ramzan Altaf U, Singh Sarabjeet, Siddiqi Mushtaq A, Bhat Abdul |
| High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients. Experimental & molecular medicine 2017 Apr 49 (4): e317. Cho Sung-Yup, Park Changho, Na Deukchae, Han Jee Yun, Lee Jieun, Park Ok-Kyoung, Zhang Chengsheng, Sung Chang Ohk, Moon Hyo Eun, Kim Yona, Kim Jeong Hoon, Kim Jong Jae, Khang Shin Kwang, Nam Do-Hyun, Choi Jung Won, Suh Yeon-Lim, Kim Dong Gyu, Park Sung Hye, Youn Hyewon, Yun Kyuson, Kim Jong-Il, Lee Charles, Paek Sun Ha, Park Hans |
| GBM-associated mutations and altered protein expression are more common in young patients. Oncotarget 2016 Aug . Ferguson Sherise D, Xiu Joanne, Weathers Shiao-Pei, Zhou Shouhao, Kesari Santosh, Weiss Stephanie E, Verhaak Roeland G, Hohl Raymond J, Barger Geoffrey R, Reddy Sandeep K, Heimberger Amy |
| Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
| Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status. Neuroscience 2015 Jun 297 243-51. Navarro L, Gil-Benso R, Megías J, Muñoz-Hidalgo L, San-Miguel T, Callaghan R C, González-Darder J M, López-Ginés C, Cerdá-Nicolás M |
| Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation. Oncology letters 2015 May 9 (5): 2063-2067. McDonald Kerrie L, Tabone Tania, Nowak Anna K, Erber Wendy |
| Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy. International journal of clinical and experimental pathology 2015 8 (5): 5327-35. Tang Chao, Guo Jun, Chen Hong, Yao Cheng-Jun, Zhuang Dong-Xiao, Wang Yin, Tang Wei-Jun, Ren Guang, Yao Yu, Wu Jin-Song, Mao Ying, Zhou Liang- |
| Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab. International journal of oncology 2012 Sep 41 (3): 1029-35. Lv Shasha, Teugels Erik, Sadones Jan, De Brakeleer Sylvia, Duerinck Johnny, Du Four Stephanie, Michotte Alex, De Grève Jacques, Neyns Ba |
| Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta neurochirurgica 2009 Nov 151 (11): 1349-58. Sonoda Yukihiko, Kumabe Toshihiro, Watanabe Mika, Nakazato Yoichi, Inoue Tomoo, Kanamori Masayuki, Tominaga Tei |
| Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration. American journal of clinical pathology 2009 Feb 131 (2): 257-63. Ruano Yolanda, Ribalta Teresa, de Lope Angel Rodríguez, Campos-Martín Yolanda, Fiaño Concepción, Pérez-Magán Elisa, Hernández-Moneo José-Luis, Mollejo Manuela, Meléndez Bárba |
| PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2004 Jan 11 (1): 37-41. Kato Hideaki, Fujimura Miki, Kumabe Toshihiro, Ishioka Chikashi, Kanamaru Ryunosuke, Yoshimoto Takas |
| PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. Journal of the National Cancer Institute 2001 Aug 93 (16): 1246-56. Smith J S, Tachibana I, Passe S M, Huntley B K, Borell T J, Iturria N, O'Fallon J R, Schaefer P L, Scheithauer B W, James C D, Buckner J C, Jenkins R |
| Significant Effect of Anti-tyrosine Kinase Inhibitor (Gefitinib) on Overall Survival of the Glioblastoma Multiforme Patients in the Backdrop of Mutational Status of Epidermal Growth Factor Receptor and PTEN Genes. Asian journal of neurosurgery 0 13 (1): 46-52. Arif Sajad Hussain, Pandith Arshad Ahmad, Tabasum Rehana, Ramzan Altaf Umar, Singh Sarabjeet, Siddiqi Mushtaq Ahmad, Bhat Abdul Rash |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: